Fischer Medical Ventures Limited has announced an earnings conference call with analysts and investors on Friday, November 7, 2025, at 12:00 PM (IST). The call aims to discuss the financial results for the quarter and half-year ended September 30, 2025 (Q2 & H1 FY26). Key management, including Director Ms. Svetlana Rao, CFO Mr. Vivek Balasubramanian, and COO Mr. Shankar Varadharajan, will be present to provide insights. This virtual meeting allows stakeholders to understand the company's financial performance directly from its leadership. No unpublished price-sensitive information will be disclosed.